Cancer Risk Clinical Trials

11 recruiting

Cancer Risk Trials at a Glance

19 actively recruiting trials for cancer risk are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Wuhan, Aurora, and Bologna. Lead sponsors running cancer risk studies include Peter MacCallum Cancer Centre, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, and Future Genetics Limited.

Browse cancer risk trials by phase

Treatments under study

About Cancer Risk Clinical Trials

Looking for clinical trials for Cancer Risk? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cancer Risk trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cancer Risk clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 119 of 19 trials

Recruiting

Norris ORIEN Total Cancer Care

Cancer RiskMalignant Neoplasm
University of Southern California10,000 enrolled1 locationNCT02970045
Recruiting

Clinical Biospecimen Collection

Cancer Risk
North Shore Hematology Oncology Associates P.C dba New York Cancer and Blood Specialists900,000 enrolled1 locationNCT07543159
Recruiting
Not Applicable

Using Middle School Science Teachers to Address Cancer Health Disparities

Cancer PreventionCancer Risk Factors
Weill Medical College of Cornell University1,812 enrolled5 locationsNCT07501689
Recruiting
Not Applicable

Population Based Germline Testing for Early Detection and Prevention of Cancer

Breast Cancer Risk
Queen Mary University of London6,000 enrolled1 locationNCT07498829
Recruiting

A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

Cancer Risk
University of Colorado, Denver20,000 enrolled6 locationsNCT03617939
Recruiting
Not Applicable

Mirai-MRI: Validation of AI Models for Breast Cancer Risk

Cancer RiskBreast Cancer Risk
University of California, San Francisco400 enrolled4 locationsNCT07121972
Recruiting

Rutgers University Study of the Genetics of Breast Cancer.

Breast CancerBreast Cancer PreventionBreast Cancer Risk
Rutgers, The State University of New Jersey25,000 enrolled1 locationNCT06773897
Recruiting

CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management

Cancer Risk
Hackensack Meridian Health10,000 enrolled1 locationNCT06804395
Recruiting

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Lung CancerCancer RiskCancer Predisposition Syndrome+28 more
Dana-Farber Cancer Institute5,000 enrolled1 locationNCT05463796
Recruiting
Not Applicable

The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities

Colorectal Cancer PreventionColorectal Cancer Risk
Purdue University40 enrolled2 locationsNCT07086833
Recruiting

Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

CancerCancer Risk
New Mexico Cancer Research Alliance47,500 enrolled1 locationNCT03977402
Recruiting

Development of New Methodologies and Innovative Tools for the diagnoSi and Therapeutic Treatment of uMAni Epithelial Tumors

Cancer RiskBreast Cancer RiskLung Cancer (NSCLC)
ASL Lecce250 enrolled1 locationNCT06939049
Recruiting

EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality

Heart FailureLung CancersProstate Cancer+19 more
Future Genetics Limited200,000 enrolled1 locationNCT03987633
Recruiting

Implementation of Personalised Risk Assessment in Oncogenetics

Prostate cancer risk assessmentBowel cancer risk assessmentOvarian cancer risk assessment+1 more
Peter MacCallum Cancer Centre2,000 enrolled3 locationsACTRN12625000065493
Recruiting

Night-shift Work and Breast Cancer

Breast Cancer Risk Factors
IRCCS Azienda Ospedaliero-Universitaria di Bologna6,000 enrolled2 locationsNCT06786949
Recruiting

Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment

Lung CancerColon CancerStomach Cancer+6 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology3,000 enrolled1 locationNCT06653478
Recruiting

Testing the impact of a innovative digital resource, ActionPlan, on familial cancer patient empowerment.

living with a BRCA2 pathogenic variantLiving with a PALB2 pathogenic variantOvarian cancer risk+2 more
Peter MacCallum Cancer Centre354 enrolled1 locationACTRN12624001200572
Recruiting

Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment

Lung CancerColon CancerStomach Cancer+6 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology3,000 enrolled1 locationNCT05426135
Recruiting

Morehouse Total Cancer Care Protocol

CancerCancer Risk
Morehouse School of Medicine5,000 enrolled1 locationNCT04804878